Last reviewed · How we verify
NCT06965439
Effectiveness of AI Chatbots in Improving Students' General Wellbeing
NA trial testing AI-delivered emotional wellbeing support in Control Condition in 172 participants. Not yet recruiting.
31 October 2025
Quick facts
| Lead sponsor | National University of Singapore |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | factorial |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 172 |
| Start date | 1 August 2025 |
| Primary completion | 31 October 2025 |
| Estimated completion | 31 October 2025 |
Drugs / interventions tested
- AI-delivered emotional wellbeing support
- Neutral writing tasks
Conditions studied
- Control Condition — all drugs for Control Condition →
- Intervention — all drugs for Intervention →
Sponsor
National University of Singapore
Who can join
18 and older, any sex, with Control Condition or Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomised controlled trial is to evaluate the effectiveness of an AI mental health chatbot in promoting emotional wellbeing and perceived empathy among university students in Singapore with mild or subclinical symptoms of anxiety and depression. The main questions it aims to answer are: Can the chatbot provide emotional validation and be perceived as empathic? Does the chatbot reduce symptoms of anxiety and depression and improve wellbeing more than an inactive control condition? Researchers will compare students who engage in four sessions with the chatbot to students who complete four neutral writing tasks to assess differences in emotional wellbeing, empathy, and resilience. Participants will: Complete baseline wellbeing assessments Be randomised to: Four 20-minute chatbot sessions providing personalised support using cognitive-behavioural and compassion-focused techniques (intervention group), or Four 20-minute neutral writing sessions unrelated to mental health (control group) Complete post-session and follow-up wellbeing questionnaires All sessions are conducted virtually over Zoom. Participants are full-time students at the National University of Singapore, aged 21 and above. The study aims to inform future development of AI tools for emotional support in non-clinical settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06965439
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Control Condition
Currently open trials in the same condition.
- NCT07477067 — Exercise and Protein Efficiency in T2D · NA · recruiting
- NCT07350434 — Hip Abduction and Adduction During Neurodynamic Stretching · NA · recruiting
- NCT07384754 — Foot Strengthening to Improve Balance and Gait in Older Adults · NA · recruiting
- NCT06872762 — Effect of Exercise and Heat Stress on Acute Cardiometabolic Adaptations in Healthy Young Adults · NA · recruiting
- NCT07113626 — Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam · NA · recruiting
Other National University of Singapore trials
Trials by the same sponsor.
- NCT07519642 — Frailty Improvement Through Technology With Informal Caregiver Supported Exercise (FITWISE) for Pre-frail and Frail Comm · NA · not yet recruiting
- NCT07525492 — Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial · NA · not yet recruiting
- NCT07375459 — Community-based Mobile-assisted Brief Intervention for Smoking Cessation · NA · recruiting
- NCT07444073 — Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock · not yet recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06965439 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National University of Singapore
- Last refreshed: 11 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06965439.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing